更多...
收起
ERBB2基因(以及对应的蛋白质)的细胞分布位置:
ERBB2基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Neoplasm Metastasis | 0.331048018 | 371 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Mammary Neoplasms | 0.289468128 | 538 | 0 | BeFree_CTD_human_GAD_LHGDN |
ovarian neoplasm | 0.279458387 | 56 | 1 | BeFree_CLINVAR_CTD_human_LHGDN |
Stomach Neoplasms | 0.263152011 | 16 | 1 | BeFree_CLINVAR_CTD_human_LHGDN |
Malignant neoplasm of breast | 0.24 | 2853 | 22 | BeFree_GAD_MGD |
Adenocarcinoma | 0.213796419 | 211 | 0 | BeFree_CTD_human_LHGDN |
Mammary Neoplasms, Experimental | 0.2 | 3 | 0 | CTD_human_RGD |
Carcinogenesis | 0.168859537 | 181 | 2 | BeFree_CTD_human |
Lung Neoplasms | 0.153496597 | 24 | 0 | BeFree_CTD_human_LHGDN |
Prostatic Neoplasms | 0.153496597 | 25 | 0 | BeFree_CTD_human_LHGDN |
Non-Small Cell Lung Carcinoma | 0.14605842 | 96 | 9 | BeFree_CLINVAR |
Cholangiocarcinoma | 0.131430353 | 14 | 0 | BeFree_CTD_human_LHGDN |
Glioma | 0.130801593 | 13 | 0 | BeFree_CTD_human_GAD_LHGDN |
Esophageal Neoplasms | 0.127252986 | 20 | 0 | BeFree_CTD_human_GAD |
Animal Mammary Neoplasms | 0.127101096 | 4 | 0 | CTD_human_GAD |
Adenocarcinoma of lung (disorder) | 0.127057489 | 26 | 3 | BeFree_CLINVAR |
Medulloblastoma | 0.12408156 | 6 | 0 | BeFree_CTD_human_LHGDN |
Renal Cell Carcinoma | 0.123800186 | 14 | 0 | BeFree_CTD_human |
Colonic Neoplasms | 0.123538676 | 5 | 0 | BeFree_CTD_human_LHGDN |
Neoplasms, Experimental | 0.122367032 | 2 | 0 | CTD_human_GAD |
Papilloma | 0.120814326 | 4 | 0 | BeFree_CTD_human |
Gastrointestinal Neoplasms | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Lymphatic Metastasis | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Nasopharyngeal carcinoma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
gallbladder neoplasm | 0.12 | 1 | 0 | CTD_human |
Neoplasm Recurrence, Local | 0.12 | 1 | 0 | CTD_human |
Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
Disease Progression | 0.12 | 2 | 0 | CTD_human |
GLIOMA SUSCEPTIBILITY 1 | 0.12 | 0 | 1 | CLINVAR |
Mouth Neoplasms | 0.084734064 | 3 | 0 | GAD_RGD |
Heart failure | 0.080814326 | 4 | 0 | BeFree_RGD |
Wallerian Degeneration | 0.08 | 1 | 0 | RGD |
Breast Carcinoma | 0.08 | 2746 | 22 | BeFree |
Median Neuropathy | 0.08 | 1 | 0 | RGD |
Diabetic Cardiomyopathies | 0.08 | 1 | 0 | RGD |
Carcinoma breast stage IV | 0.078989585 | 291 | 0 | BeFree |
Malignant neoplasm of stomach | 0.070151555 | 241 | 2 | BeFree_GAD |
Stomach Carcinoma | 0.068946236 | 254 | 2 | BeFree |
Ovarian Carcinoma | 0.058360002 | 215 | 0 | BeFree |
Malignant neoplasm of ovary | 0.053517656 | 172 | 0 | BeFree_GAD |
Malignant neoplasm of lung | 0.044842786 | 85 | 1 | BeFree_GAD |
Triple Negative Breast Neoplasms | 0.043702141 | 161 | 0 | BeFree |
Squamous cell carcinoma | 0.04099123 | 69 | 0 | BeFree_GAD_LHGDN |
Invasive breast carcinoma | 0.032301583 | 119 | 2 | BeFree |
Noninfiltrating Intraductal Carcinoma | 0.027988307 | 74 | 0 | BeFree_LHGDN |
Secondary malignant neoplasm of lymph node | 0.027144187 | 100 | 0 | BeFree |
Malignant neoplasm of prostate | 0.026449414 | 80 | 0 | BeFree_GAD |
Colorectal Neoplasms | 0.022880569 | 12 | 0 | BeFree_LHGDN |
Prostate carcinoma | 0.022801117 | 84 | 0 | BeFree |
Tumor Progression | 0.022258234 | 82 | 0 | BeFree |
Epithelial ovarian cancer | 0.020825079 | 69 | 0 | BeFree_GAD |
Ductal Carcinoma | 0.020126425 | 38 | 0 | BeFree_LHGDN |
Osteosarcoma | 0.018769215 | 29 | 0 | BeFree_LHGDN |
Endometrial Carcinoma | 0.018653544 | 60 | 0 | BeFree_GAD |
Carcinoma of lung | 0.018458047 | 68 | 1 | BeFree |
Carcinoma, Transitional Cell | 0.017140564 | 25 | 0 | BeFree_LHGDN |
Colorectal Cancer | 0.015396242 | 49 | 1 | BeFree_GAD |
Malignant neoplasm of urinary bladder | 0.014505971 | 38 | 0 | BeFree_GAD |
Colorectal Carcinoma | 0.013843535 | 51 | 1 | BeFree |
Invasive Ductal Breast Carcinoma | 0.013300652 | 49 | 1 | BeFree |
Endometrial Neoplasms | 0.012907115 | 5 | 0 | GAD_LHGDN |
Bladder Neoplasm | 0.012797494 | 11 | 0 | BeFree_LHGDN |
Carcinoma of bladder | 0.011129117 | 41 | 0 | BeFree |
Inflammatory Breast Carcinoma | 0.009500466 | 35 | 0 | BeFree |
Uterine Corpus Cancer | 0.009500466 | 35 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.009229024 | 34 | 0 | BeFree |
Metastatic malignant neoplasm to brain | 0.009229024 | 34 | 0 | BeFree |
Mammary Tumorigenesis | 0.00868614 | 32 | 0 | BeFree |
Cervix carcinoma | 0.008610195 | 23 | 0 | BeFree_GAD |
Pancreatic carcinoma | 0.008414698 | 31 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.008414698 | 31 | 0 | BeFree |
Early-Stage Breast Carcinoma | 0.008414698 | 31 | 0 | BeFree |
Mixed Salivary Gland Tumor | 0.007891677 | 11 | 0 | BeFree_LHGDN |
melanoma | 0.007881746 | 19 | 0 | BeFree_LHGDN |
synovial sarcoma | 0.007620235 | 8 | 0 | BeFree_LHGDN |
Esophageal carcinoma | 0.007057489 | 26 | 0 | BeFree |
Osteosarcoma of bone | 0.006786047 | 25 | 0 | BeFree |
Glioblastoma | 0.006524536 | 15 | 0 | BeFree_LHGDN |
Liver carcinoma | 0.006524536 | 14 | 0 | BeFree_LHGDN |
Solid tumour | 0.006514605 | 24 | 0 | BeFree |
Gastric Adenocarcinoma | 0.006243163 | 23 | 0 | BeFree |
Adenocarcinoma Of Esophagus | 0.005971721 | 22 | 0 | BeFree |
Malignant neoplasm of esophagus | 0.005971721 | 22 | 0 | BeFree |
Thyroid Neoplasm | 0.005634266 | 4 | 0 | BeFree_GAD_LHGDN |
Anoxia | 0.0054487 | 2 | 0 | LHGDN |
Cessation of life | 0.0054487 | 2 | 0 | LHGDN |
Pancreatic Neoplasm | 0.005362824 | 3 | 0 | BeFree_GAD_LHGDN |
Fibroadenoma | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
Small cell carcinoma of lung | 0.005167327 | 9 | 0 | BeFree_LHGDN |
Xenograft Model | 0.005157396 | 19 | 0 | BeFree |
Carcinoma, Papillary | 0.004895885 | 8 | 0 | BeFree_LHGDN |
Nephroblastoma | 0.004895885 | 9 | 0 | BeFree_LHGDN |
Adenoma | 0.004624443 | 8 | 0 | BeFree_LHGDN |
Malignant tumor of cervix | 0.004614512 | 17 | 0 | BeFree |
CNS metastases | 0.004614512 | 17 | 0 | BeFree |
Epithelioma | 0.004614512 | 17 | 0 | BeFree |
Cardiomyopathy, Familial Idiopathic | 0.004614512 | 17 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.00434307 | 16 | 0 | BeFree |
Brain Neoplasms | 0.004267125 | 8 | 0 | BeFree_GAD |
Herpes Simplex Infections | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Acoustic Neuroma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Retinoblastoma | 0.00408156 | 5 | 0 | BeFree_LHGDN |
Carcinoma, Large Cell | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Precancerous Conditions | 0.004071628 | 15 | 2 | BeFree |
Breast cancer recurrent | 0.004071628 | 15 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.004071628 | 15 | 0 | BeFree |
Carcinoma of Male Breast | 0.003800186 | 14 | 1 | BeFree |
Transitional cell carcinoma of bladder | 0.003800186 | 14 | 0 | BeFree |
Invasive Carcinoma | 0.003800186 | 14 | 0 | BeFree |
Obesity | 0.003724241 | 5 | 0 | BeFree_GAD |
Malignant neoplasm of mouth | 0.003724241 | 6 | 0 | BeFree_GAD |
Malignant tumor of colon | 0.003528744 | 13 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.003528744 | 13 | 0 | BeFree |
Colon Carcinoma | 0.003528744 | 13 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.003528744 | 13 | 0 | BeFree |
Salivary duct carcinoma | 0.003528744 | 13 | 0 | BeFree |
Rheumatoid Arthritis | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Gastrinoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Acute Erythroblastic Leukemia | 0.003257302 | 12 | 0 | BeFree |
Cystadenocarcinoma, Serous | 0.003257302 | 12 | 0 | BeFree |
Malignant neoplasm of male breast | 0.003257302 | 12 | 1 | BeFree |
Recurrent tumor | 0.003257302 | 12 | 0 | BeFree |
Breast adenocarcinoma | 0.003257302 | 12 | 0 | BeFree |
Mammary Carcinoma, Human | 0.003257302 | 12 | 0 | BeFree |
Sarcoma | 0.003257302 | 12 | 0 | BeFree |
Ductal Breast Carcinoma | 0.003257302 | 12 | 0 | BeFree |
Urothelial Carcinoma | 0.003257302 | 12 | 0 | BeFree |
Cardiomyopathy, Dilated | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Hodgkin Disease | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Polycystic Kidney Diseases | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Pheochromocytoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Pulmonary Fibrosis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Invasive Lobular Breast Carcinoma | 0.002985861 | 11 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.002985861 | 11 | 0 | BeFree |
Breast Cancer Model | 0.002985861 | 11 | 0 | BeFree |
Non-Neoplastic Disorder | 0.002985861 | 11 | 0 | BeFree |
Charcot-Marie-Tooth Disease | 0.00272435 | 1 | 0 | LHGDN |
Fibroid Tumor | 0.00272435 | 1 | 0 | LHGDN |
Pneumoconiosis | 0.00272435 | 1 | 0 | LHGDN |
Tongue Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Nerve Sheath Tumors | 0.00272435 | 1 | 0 | LHGDN |
Papillomavirus Infections | 0.00272435 | 1 | 0 | LHGDN |
Prostatic Hyperplasia | 0.00272435 | 1 | 0 | LHGDN |
Trigeminal Neuralgia | 0.002714419 | 10 | 0 | BeFree |
Breast Cancer, Familial | 0.002714419 | 10 | 1 | BeFree |
invasive cancer | 0.002714419 | 10 | 0 | BeFree |
Heart Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
Laryngeal neoplasm | 0.002638474 | 2 | 0 | BeFree_GAD |
Oral Cavity Carcinoma | 0.002638474 | 2 | 0 | BeFree_GAD |
Squamous cell carcinoma of skin | 0.002638474 | 2 | 0 | BeFree_GAD |
Female Breast Carcinoma | 0.002442977 | 9 | 0 | BeFree |
Carcinoma, Lobular | 0.002442977 | 9 | 0 | BeFree |
Comedone | 0.002442977 | 9 | 0 | BeFree |
Malignant neoplasm of stomach stage IV | 0.002442977 | 9 | 0 | BeFree |
Neoplastic Cell Transformation | 0.002367032 | 1 | 0 | GAD |
Cleft Lip | 0.002367032 | 1 | 1 | GAD |
Cleft Palate | 0.002367032 | 1 | 1 | GAD |
Head and Neck Neoplasms | 0.002367032 | 1 | 0 | GAD |
Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
Pharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Tooth Abnormalities | 0.002367032 | 1 | 1 | GAD |
Adenocarcinoma of prostate | 0.002171535 | 8 | 0 | BeFree |
Carcinoma, Endometrioid | 0.002171535 | 8 | 0 | BeFree |
Adenocarcinoma of pancreas | 0.002171535 | 8 | 0 | BeFree |
Thyroid carcinoma | 0.002171535 | 8 | 0 | BeFree |
Intraepithelial Neoplasia | 0.002171535 | 8 | 0 | BeFree |
Carcinosarcoma | 0.001900093 | 7 | 0 | BeFree |
Adenoid Cystic Carcinoma | 0.001900093 | 7 | 0 | BeFree |
Meningioma | 0.001900093 | 7 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.001900093 | 7 | 0 | BeFree |
Progressive Neoplastic Disease | 0.001900093 | 7 | 0 | BeFree |
malignant neoplasm of breast staging | 0.001900093 | 7 | 0 | BeFree |
Progressive cGVHD | 0.001900093 | 7 | 0 | BeFree |
Rectal Carcinoma | 0.001628651 | 6 | 0 | BeFree |
Mucinous Adenocarcinoma | 0.001628651 | 6 | 0 | BeFree |
Myeloid Leukemia, Chronic | 0.001628651 | 6 | 1 | BeFree |
Severe Combined Immunodeficiency | 0.001628651 | 6 | 0 | BeFree |
Benign Neoplasm | 0.001628651 | 6 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.001628651 | 6 | 0 | BeFree |
Gallbladder Carcinoma | 0.001628651 | 6 | 0 | BeFree |
Carcinoma ex pleomorphic adenoma | 0.001628651 | 6 | 0 | BeFree |
Adenocarcinoma, Endometrioid | 0.001628651 | 6 | 0 | BeFree |
Benign Prostatic Hyperplasia | 0.001628651 | 6 | 0 | BeFree |
Breast Fibrocystic Disease | 0.001357209 | 5 | 0 | BeFree |
Malignant neoplasm of gallbladder | 0.001357209 | 5 | 0 | BeFree |
Agenesis of corpus callosum | 0.001357209 | 5 | 0 | BeFree |
Intestinal Cancer | 0.001357209 | 5 | 0 | BeFree |
Complete hydatidiform mole | 0.001357209 | 5 | 0 | BeFree |
Biliary Tract Cancer | 0.001357209 | 5 | 0 | BeFree |
Rhabdoid Tumor of the Kidney | 0.001357209 | 5 | 0 | BeFree |
Gastrooesophageal cancer | 0.001357209 | 5 | 0 | BeFree |
Gestational Trophoblastic Neoplasms | 0.001357209 | 5 | 0 | BeFree |
Endometrial adenocarcinoma | 0.001357209 | 5 | 0 | BeFree |
Adenocarcinoma of the gastroesophageal junction | 0.001357209 | 5 | 1 | BeFree |
Sporadic Breast Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Tumor Angiogenesis | 0.001357209 | 5 | 0 | BeFree |
Tumor Immunity | 0.001357209 | 5 | 0 | BeFree |
HYDATIDIFORM MOLE, RECURRENT, 1 | 0.001357209 | 5 | 0 | BeFree |
Micropapillary carcinoma | 0.001357209 | 5 | 0 | BeFree |
Breast Diseases | 0.001085767 | 4 | 0 | BeFree |
Congestive heart failure | 0.001085767 | 4 | 0 | BeFree |
Hydatidiform Mole | 0.001085767 | 4 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.001085767 | 4 | 0 | BeFree |
leukemia | 0.001085767 | 4 | 0 | BeFree |
Acute Promyelocytic Leukemia | 0.001085767 | 4 | 1 | BeFree |
Liver neoplasms | 0.001085767 | 4 | 1 | BeFree |
Neurilemmoma | 0.001085767 | 4 | 0 | BeFree |
Li-Fraumeni Syndrome | 0.001085767 | 4 | 0 | BeFree |
Stage 0 Breast Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Adenocarcinoma, Tubular | 0.001085767 | 4 | 0 | BeFree |
Germ cell tumor | 0.001085767 | 4 | 0 | BeFree |
Medullary carcinoma | 0.001085767 | 4 | 0 | BeFree |
Mucoepidermoid Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Cervical Intraepithelial Neoplasia | 0.001085767 | 4 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of female breast | 0.001085767 | 4 | 0 | BeFree |
Fallopian Tube Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Medullary carcinoma of thyroid | 0.001085767 | 4 | 0 | BeFree |
Carcinoma, Small Cell | 0.001085767 | 4 | 0 | BeFree |
Cervical Squamous Cell Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Cervical Adenocarcinoma | 0.001085767 | 4 | 0 | BeFree |
Uterine Carcinosarcoma | 0.001085767 | 4 | 0 | BeFree |
Disseminated Malignant Neoplasm | 0.001085767 | 4 | 0 | BeFree |
Secondary malignant neoplasm of axilla | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of gastrointestinal tract | 0.001085767 | 4 | 0 | BeFree |
Metastatic Prostate Carcinoma | 0.001085767 | 4 | 0 | BeFree |
Contralateral breast cancer | 0.001085767 | 4 | 0 | BeFree |
Single tumor | 0.001085767 | 4 | 0 | BeFree |
Desmoplastic | 0.001085767 | 4 | 0 | BeFree |
Cancer Cell Growth | 0.001085767 | 4 | 0 | BeFree |
Non-Malignant Ascites Adverse Event | 0.001085767 | 4 | 0 | BeFree |
androgen independent prostate cancer | 0.001085767 | 4 | 0 | BeFree |
Uterine Corpus Carcinosarcoma | 0.001085767 | 4 | 0 | BeFree |
Anaplasia | 0.000814326 | 3 | 0 | BeFree |
Astrocytoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000814326 | 3 | 0 | BeFree |
Choriocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Congenital chromosomal disease | 0.000814326 | 3 | 0 | BeFree |
granulosa cell tumor | 0.000814326 | 3 | 0 | BeFree |
Hepatitis B | 0.000814326 | 3 | 0 | BeFree |
Mammary Ductal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Leprosy | 0.000814326 | 3 | 0 | BeFree |
Lymphoma | 0.000814326 | 3 | 0 | BeFree |
Measles | 0.000814326 | 3 | 0 | BeFree |
Monosomy | 0.000814326 | 3 | 0 | BeFree |
Neuroblastoma | 0.000814326 | 3 | 0 | BeFree |
Paget Disease Extramammary | 0.000814326 | 3 | 0 | BeFree |
Pituitary Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Prolactinoma | 0.000814326 | 3 | 0 | BeFree |
Salivary Gland Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Skin Neoplasms | 0.000814326 | 3 | 0 | BeFree |
Pancreatitis, Chronic | 0.000814326 | 3 | 0 | BeFree |
Cutaneous Melanoma | 0.000814326 | 3 | 0 | BeFree |
Meningeal Carcinomatosis | 0.000814326 | 3 | 0 | BeFree |
Neoplasm, Residual | 0.000814326 | 3 | 0 | BeFree |
Vesicular Stomatitis | 0.000814326 | 3 | 0 | BeFree |
Erythroblastosis | 0.000814326 | 3 | 0 | BeFree |
Breast cancer stage II | 0.000814326 | 3 | 0 | BeFree |
Stage III Breast Cancer AJCC v6 | 0.000814326 | 3 | 0 | BeFree |
Metastatic osteosarcoma | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma of small intestine | 0.000814326 | 3 | 0 | BeFree |
Metastatic melanoma | 0.000814326 | 3 | 0 | BeFree |
bilateral breast cancer | 0.000814326 | 3 | 0 | BeFree |
Papillary serous cystadenocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Intrahepatic Cholangiocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Refractory cancer | 0.000814326 | 3 | 0 | BeFree |
Sentinel node (disorder) | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000814326 | 3 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.000814326 | 3 | 0 | BeFree |
High-Grade Prostatic Intraepithelial Neoplasia | 0.000814326 | 3 | 0 | BeFree |
Adenocarcinoma of large intestine | 0.000814326 | 3 | 0 | BeFree |
Hormone refractory prostate cancer | 0.000814326 | 3 | 0 | BeFree |
Atypical Ductal Breast Hyperplasia | 0.000814326 | 3 | 0 | BeFree |
Primary Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Primary Lesion | 0.000814326 | 3 | 0 | BeFree |
Glioblastoma Multiforme | 0.000814326 | 3 | 0 | BeFree |
Meningioma, benign, no ICD-O subtype | 0.000814326 | 3 | 0 | BeFree |
Gestational trophoblastic disease | 0.000814326 | 3 | 0 | BeFree |
Breast cancer, lobular | 0.000814326 | 3 | 0 | BeFree |
Basal-Like Breast Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Melanoma, B16 | 0.000542884 | 2 | 0 | BeFree |
Barrett Esophagus | 0.000542884 | 2 | 0 | BeFree |
Bone neoplasms | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of larynx | 0.000542884 | 2 | 0 | BeFree |
Bronchioloalveolar Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
CNS disorder | 0.000542884 | 2 | 0 | BeFree |
Diarrhea | 0.000542884 | 2 | 0 | BeFree |
Endometriosis | 0.000542884 | 2 | 0 | BeFree |
Exanthema | 0.000542884 | 2 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.000542884 | 2 | 0 | BeFree |
Lymphoma, Non-Hodgkin | 0.000542884 | 2 | 0 | BeFree |
Neck Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Nodule | 0.000542884 | 2 | 0 | BeFree |
Paraganglioma | 0.000542884 | 2 | 0 | BeFree |
Rhabdomyosarcoma | 0.000542884 | 2 | 0 | BeFree |
Schistosomiasis | 0.000542884 | 2 | 0 | BeFree |
Soft Tissue Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Thoracic Outlet Syndrome | 0.000542884 | 2 | 0 | BeFree |
Ichthyosis, X-Linked | 0.000542884 | 2 | 0 | BeFree |
B-Cell Lymphomas | 0.000542884 | 2 | 0 | BeFree |
Polycystic Kidney, Autosomal Dominant | 0.000542884 | 2 | 0 | BeFree |
Adenosis of Breast | 0.000542884 | 2 | 0 | BeFree |
Thyroid Gland Follicular Adenoma | 0.000542884 | 2 | 0 | BeFree |
Uterine Cancer | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of testis | 0.000542884 | 2 | 0 | BeFree |
Follicular adenoma | 0.000542884 | 2 | 0 | BeFree |
Pulmonary Blastoma | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma, Clear Cell | 0.000542884 | 2 | 0 | BeFree |
Carcinoma, Signet Ring Cell | 0.000542884 | 2 | 0 | BeFree |
Neuroendocrine Tumors | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of salivary gland | 0.000542884 | 2 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
Papillary thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
Endometrioma | 0.000542884 | 2 | 0 | BeFree |
Cancer of Head and Neck | 0.000542884 | 2 | 0 | BeFree |
Lobular carcinoma in situ of breast | 0.000542884 | 2 | 0 | BeFree |
Gallbladder adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
stage, non-small cell lung cancer | 0.000542884 | 2 | 0 | BeFree |
stage, ovarian epithelial cancer | 0.000542884 | 2 | 0 | BeFree |
Prostatic Intraepithelial Neoplasias | 0.000542884 | 2 | 0 | BeFree |
Tumor necrosis | 0.000542884 | 2 | 0 | BeFree |
Non-infiltrating lobular carcinoma | 0.000542884 | 2 | 0 | BeFree |
Endometrioid carcinoma ovary | 0.000542884 | 2 | 0 | BeFree |
Multiple malignancy | 0.000542884 | 2 | 0 | BeFree |
Secondary malignant neoplasm of pancreas | 0.000542884 | 2 | 0 | BeFree |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
Hematologic Neoplasms | 0.000542884 | 2 | 0 | BeFree |
Neurodegenerative Disorders | 0.000542884 | 2 | 0 | BeFree |
Malignant Glioma | 0.000542884 | 2 | 0 | BeFree |
Cerebral metastasis | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of larynx | 0.000542884 | 2 | 0 | BeFree |
Tumor Initiation | 0.000542884 | 2 | 0 | BeFree |
Central neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
Stage I Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Spots on skin | 0.000542884 | 2 | 0 | BeFree |
Helicobacter pylori infection | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma of lung, stage IV | 0.000542884 | 2 | 1 | BeFree |
Testicular malignant germ cell tumor | 0.000542884 | 2 | 0 | BeFree |
Borderline ovarian tumour | 0.000542884 | 2 | 0 | BeFree |
Advanced cancer | 0.000542884 | 2 | 0 | BeFree |
Cardiomyopathies | 0.000542884 | 2 | 0 | BeFree |
cancer recurrence | 0.000542884 | 2 | 0 | BeFree |
precancerous lesions | 0.000542884 | 2 | 0 | BeFree |
Ovarian adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Colorectal cancer metastatic | 0.000542884 | 2 | 0 | BeFree |
Nonseminomatous germ cell tumor | 0.000542884 | 2 | 0 | BeFree |
Infiltrating Cervical Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Intraductal Proliferative Lesion of the Breast | 0.000542884 | 2 | 0 | BeFree |
Renal carcinoma | 0.000542884 | 2 | 0 | BeFree |
Infiltrating duct carcinoma | 0.000542884 | 2 | 0 | BeFree |
Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000542884 | 2 | 0 | BeFree |
Apocrine Gland Carcinoma | 0.000542884 | 2 | 0 | BeFree |
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | 0.000542884 | 2 | 0 | BeFree |
Triple-Negative Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Clear-cell metastatic renal cell carcinoma | 0.000542884 | 2 | 0 | BeFree |
Stage III Breast Cancer AJCC v7 | 0.000542884 | 2 | 0 | BeFree |
Mammary adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Congenital Abnormality | 0.000271442 | 1 | 0 | BeFree |
Renal tubular acidosis | 0.000271442 | 1 | 0 | BeFree |
Acute pancreatitis | 0.000271442 | 1 | 0 | BeFree |
Papillary adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Adenosarcoma | 0.000271442 | 1 | 0 | BeFree |
Anemia | 0.000271442 | 1 | 0 | BeFree |
Anthrax disease | 0.000271442 | 1 | 0 | BeFree |
Aortic Valve Insufficiency | 0.000271442 | 1 | 0 | BeFree |
Bone Diseases | 0.000271442 | 1 | 0 | BeFree |
Carcinoid Tumor | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of skin | 0.000271442 | 1 | 0 | BeFree |
Merkel cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Celiac Disease | 0.000271442 | 1 | 0 | BeFree |
Cerebral Embolism | 0.000271442 | 1 | 0 | BeFree |
Cholera | 0.000271442 | 1 | 0 | BeFree |
Cystitis | 0.000271442 | 1 | 0 | BeFree |
Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
Decompression Sickness | 0.000271442 | 1 | 0 | BeFree |
Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Diabetes Insipidus | 0.000271442 | 1 | 0 | BeFree |
Patent ductus arteriosus | 0.000271442 | 1 | 0 | BeFree |
Empty Sella Syndrome | 0.000271442 | 1 | 0 | BeFree |
Endocrine Gland Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Epidermodysplasia Verruciformis | 0.000271442 | 1 | 0 | BeFree |
Eyelid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Fibrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Glomerulonephritis | 0.000271442 | 1 | 0 | BeFree |
Gynecomastia | 0.000271442 | 1 | 0 | BeFree |
Hepatitis A | 0.000271442 | 1 | 0 | BeFree |
Hyperinsulinism | 0.000271442 | 1 | 0 | BeFree |
Intestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Kartagener Syndrome | 0.000271442 | 1 | 0 | BeFree |
Kidney Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Acute lymphocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Liver Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
Lupus Vulgaris | 0.000271442 | 1 | 0 | BeFree |
Lupus Erythematosus, Discoid | 0.000271442 | 1 | 0 | BeFree |
Lupus Erythematosus, Systemic | 0.000271442 | 1 | 0 | BeFree |
Lupus Nephritis | 0.000271442 | 1 | 0 | BeFree |
Lymphoproliferative Disorders | 0.000271442 | 1 | 0 | BeFree |
Meningitis | 0.000271442 | 1 | 0 | BeFree |
Multiple Myeloma | 0.000271442 | 1 | 0 | BeFree |
Nasopharyngeal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Nervous System Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Neurofibromatosis 1 | 0.000271442 | 1 | 0 | BeFree |
Nevus | 0.000271442 | 1 | 0 | BeFree |
Melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
Ovarian Cysts | 0.000271442 | 1 | 0 | BeFree |
Pain | 0.000271442 | 1 | 0 | BeFree |
Paraneoplastic Syndromes | 0.000271442 | 1 | 0 | BeFree |
Pericardial effusion | 0.000271442 | 1 | 0 | BeFree |
Pituitary Diseases | 0.000271442 | 1 | 0 | BeFree |
Pneumoperitoneum | 0.000271442 | 1 | 0 | BeFree |
polyps | 0.000271442 | 1 | 0 | BeFree |
Pseudotumor Cerebri | 0.000271442 | 1 | 0 | BeFree |
Systemic Scleroderma | 0.000271442 | 1 | 0 | BeFree |
Sezary Syndrome | 0.000271442 | 1 | 0 | BeFree |
Thyroiditis | 0.000271442 | 1 | 0 | BeFree |
Trisomy | 0.000271442 | 1 | 0 | BeFree |
Attention Deficit Disorder | 0.000271442 | 1 | 0 | BeFree |
Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
Central Nervous System Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Codependency | 0.000271442 | 1 | 0 | BeFree |
Juvenile-Onset Still Disease | 0.000271442 | 1 | 0 | BeFree |
nipple discharge | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
Gastric adenoma | 0.000271442 | 1 | 0 | BeFree |
Atrophic condition of skin | 0.000271442 | 1 | 0 | BeFree |
Myocardial Ischemia | 0.000271442 | 1 | 0 | BeFree |
Malignant Uterine Corpus Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
Neurofibromatoses | 0.000271442 | 1 | 0 | BeFree |
Aortic Aneurysm, Thoracic | 0.000271442 | 1 | 0 | BeFree |
Thymic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Lichen Planus, Oral | 0.000271442 | 1 | 0 | BeFree |
Alveolar rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Rhabdomyosarcoma, Embryonal | 0.000271442 | 1 | 0 | BeFree |
Adenomatous Polyps | 0.000271442 | 1 | 0 | BeFree |
Sebaceous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Neuroendocrine | 0.000271442 | 1 | 0 | BeFree |
Cystadenocarcinoma, Mucinous | 0.000271442 | 1 | 0 | BeFree |
childhood brain tumor | 0.000271442 | 1 | 0 | BeFree |
Malignant ascites | 0.000271442 | 1 | 0 | BeFree |
Fibrosing adenosis | 0.000271442 | 1 | 0 | BeFree |
Small intestine carcinoma | 0.000271442 | 1 | 0 | BeFree |
Hereditary pancreatitis | 0.000271442 | 1 | 0 | BeFree |
Epithelial inclusion cyst | 0.000271442 | 1 | 0 | BeFree |
Chronic heart failure | 0.000271442 | 1 | 0 | BeFree |
Congenital duodenal obstruction due to malrotation of intestine | 0.000271442 | 1 | 0 | BeFree |
Hypocupremia | 0.000271442 | 1 | 0 | BeFree |
Periodic Alternating Nystagmus | 0.000271442 | 1 | 0 | BeFree |
Rebound Nystagmus | 0.000271442 | 1 | 0 | BeFree |
Nystagmus, End-Position | 0.000271442 | 1 | 0 | BeFree |
Radicular pain | 0.000271442 | 1 | 0 | BeFree |
Stage IIIA Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Non-small cell lung cancer stage I | 0.000271442 | 1 | 0 | BeFree |
Medulloblastoma, Childhood | 0.000271442 | 1 | 0 | BeFree |
Non-small cell lung cancer recurrent | 0.000271442 | 1 | 0 | BeFree |
Esophageal neoplasm metastatic | 0.000271442 | 1 | 0 | BeFree |
Stage IV Ovarian Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant Childhood Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Endometrial neoplasm malignant stage I | 0.000271442 | 1 | 0 | BeFree |
Recurrent Endometrial Cancer | 0.000271442 | 1 | 0 | BeFree |
Prostate cancer recurrent | 0.000271442 | 1 | 0 | BeFree |
intestinal adenocarcinoma of the stomach | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of salivary gland | 0.000271442 | 1 | 0 | BeFree |
stage, endometrial cancer | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of oropharynx | 0.000271442 | 1 | 0 | BeFree |
Laryngeal Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Leiomyosarcoma of uterus | 0.000271442 | 1 | 0 | BeFree |
High-Grade Squamous Intraepithelial Lesions | 0.000271442 | 1 | 0 | BeFree |
Adenosis | 0.000271442 | 1 | 0 | BeFree |
Inflammatory Myofibroblastic Tumor | 0.000271442 | 1 | 0 | BeFree |
Transitional cell carcinoma in situ | 0.000271442 | 1 | 0 | BeFree |
Papillary transitional cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma, metastatic | 0.000271442 | 1 | 0 | BeFree |
Carcinoid tumor no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
Teratoma, Malignant | 0.000271442 | 1 | 0 | BeFree |
Pilocytic Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Uterine Corpus Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Leber Congenital Amaurosis | 0.000271442 | 1 | 0 | BeFree |
Epithelial tumor of ovary | 0.000271442 | 1 | 0 | BeFree |
Human papilloma virus infection | 0.000271442 | 1 | 0 | BeFree |
Pituitary carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of large intestine | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of bone marrow | 0.000271442 | 1 | 0 | BeFree |
Ischemic cardiomyopathy | 0.000271442 | 1 | 0 | BeFree |
Paraneoplastic Cerebellar Degeneration | 0.000271442 | 1 | 0 | BeFree |
Lupus Erythematosus | 0.000271442 | 1 | 0 | BeFree |
Chromosome 8, trisomy | 0.000271442 | 1 | 0 | BeFree |
Endometrioid tumor | 0.000271442 | 1 | 0 | BeFree |
Overweight | 0.000271442 | 1 | 0 | BeFree |
Chronic active hepatitis | 0.000271442 | 1 | 0 | BeFree |
Oropharyngeal disorders | 0.000271442 | 1 | 0 | BeFree |
Hyperhomocysteinemia | 0.000271442 | 1 | 0 | BeFree |
Hashimoto Disease | 0.000271442 | 1 | 0 | BeFree |
colon (non-specific) lesion | 0.000271442 | 1 | 0 | BeFree |
Primary malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
Cancer of Urinary Tract | 0.000271442 | 1 | 0 | BeFree |
Adult Acute Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Paraneoplastic Cerebellar Degeneration, Anti-Yo-Associated | 0.000271442 | 1 | 0 | BeFree |
Smith-Magenis syndrome | 0.000271442 | 1 | 0 | BeFree |
Medullary carcinoma of breast | 0.000271442 | 1 | 0 | BeFree |
Malignant melanoma, metastatic | 0.000271442 | 1 | 0 | BeFree |
Autoimmune thyroiditis | 0.000271442 | 1 | 0 | BeFree |
Bronchial dysplasia | 0.000271442 | 1 | 0 | BeFree |
Stage IV Esophageal Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Pheochromocytoma, Extra-Adrenal | 0.000271442 | 1 | 0 | BeFree |
Attention deficit hyperactivity disorder | 0.000271442 | 1 | 0 | BeFree |
Atypical medullary carcinoma | 0.000271442 | 1 | 0 | BeFree |
Intracortical osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
Low Grade Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Thymoma, type C | 0.000271442 | 1 | 0 | BeFree |
Tubular breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Breast Apocrine Adenosis | 0.000271442 | 1 | 0 | BeFree |
Apocrine breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Barrett's Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Breast Fibrocystic Change, Proliferative Type | 0.000271442 | 1 | 0 | BeFree |
Hereditary Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Tubular adenocarcinoma gastric | 0.000271442 | 1 | 0 | BeFree |
Hereditary Nonpolyposis Colorectal Cancer | 0.000271442 | 1 | 1 | BeFree |
High Grade Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Intermediate Grade Ductal Breast Carcinoma In Situ | 0.000271442 | 1 | 0 | BeFree |
Invasive Apocrine Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Invasive Ductal and Lobular Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Pulmonary Sclerosing Hemangioma | 0.000271442 | 1 | 0 | BeFree |
Malignant Mixed Mesodermal (Mullerian) Tumor | 0.000271442 | 1 | 0 | BeFree |
Metaplastic breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Breast Sclerosing Adenosis | 0.000271442 | 1 | 0 | BeFree |
Squamous Lung Dysplasia | 0.000271442 | 1 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Mixed Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Metastatic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Benign melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
Angiogenic Switch | 0.000271442 | 1 | 0 | BeFree |
Hepatocarcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Prostate Basal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Salivary Gland Pleomorphic Adenoma | 0.000271442 | 1 | 0 | BeFree |
Skin Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Hormone receptor positive tumor | 0.000271442 | 1 | 0 | BeFree |
Cold Ischemia | 0.000271442 | 1 | 0 | BeFree |
Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
Metastatic Malignant Neoplasm to the Leptomeninges | 0.000271442 | 1 | 0 | BeFree |
Sinonasal undifferentiated carcinoma | 0.000271442 | 1 | 0 | BeFree |
Unilateral Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Prostatic Hypertrophy | 0.000271442 | 1 | 0 | BeFree |
THROMBOCYTOPENIA 1 (disorder) | 0.000271442 | 1 | 0 | BeFree |
MULTICYSTIC RENAL DYSPLASIA, BILATERAL | 0.000271442 | 1 | 0 | BeFree |
BREAST CANCER 3 | 0.000271442 | 1 | 0 | BeFree |
FRIEDREICH ATAXIA 1 | 0.000271442 | 1 | 0 | BeFree |
Breast Cancer, Familial Male | 0.000271442 | 1 | 0 | BeFree |
HER2-positive carcinoma of breast | 0.000271442 | 1 | 0 | BeFree |
Epidermal growth factor receptor positive non-small cell lung cancer | 0.000271442 | 1 | 0 | BeFree |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.000271442 | 1 | 0 | BeFree |
eyelids (symptom) | 0.000271442 | 1 | 0 | BeFree |
Pleomorphic lobular carcinoma in situ | 0.000271442 | 1 | 0 | BeFree |
Cerebellar degeneration, subacute | 0.000271442 | 1 | 0 | BeFree |
Multifocal Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
GASTRIC CANCER, INTESTINAL | 0.000271442 | 1 | 0 | BeFree |
Laryngopharyngeal Cancer | 0.000271442 | 1 | 0 | BeFree |
Gastric Neuroendocrine Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Homocysteinemia | 0.000271442 | 1 | 0 | BeFree |
Ovarian low malignant potential tumour | 0.000271442 | 1 | 0 | BeFree |
RETINOSCHISIS 1, X-LINKED, JUVENILE | 0.000271442 | 1 | 0 | BeFree |
ESTROGEN RESISTANCE | 0.000271442 | 1 | 0 | BeFree |
Tumors in animals | 0.000271442 | 1 | 0 | BeFree |
Anemia in malignant neoplastic disease | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。